These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 29218825
1. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors. Basak P, Leslie H, Dillon RL, Muller WJ, Raouf A, Mowat MRA. Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825 [Abstract] [Full Text] [Related]
2. USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity. Kuang X, Salinger A, Benavides F, Muller WJ, Dent SYR, Koutelou E. PLoS One; 2024 Apr; 19(1):e0290837. PubMed ID: 38236941 [Abstract] [Full Text] [Related]
3. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J. J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969 [Abstract] [Full Text] [Related]
4. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS. Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [Abstract] [Full Text] [Related]
5. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis. Wellberg EA, Johnson S, Finlay-Schultz J, Lewis AS, Terrell KL, Sartorius CA, Abel ED, Muller WJ, Anderson SM. Breast Cancer Res; 2016 Dec 20; 18(1):131. PubMed ID: 27998284 [Abstract] [Full Text] [Related]
6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P. Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418 [Abstract] [Full Text] [Related]
7. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development. Jolicoeur P, Bouchard L, Guimond A, Ste-Marie M, Hanna Z, Dievart A. Biochem Soc Symp; 1998 May 01; 63():159-65. PubMed ID: 9513720 [Abstract] [Full Text] [Related]
16. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Proc Natl Acad Sci U S A; 1992 Nov 15; 89(22):10578-82. PubMed ID: 1359541 [Abstract] [Full Text] [Related]
18. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL. Proc Natl Acad Sci U S A; 2000 Aug 15; 97(17):9609-14. PubMed ID: 10931950 [Abstract] [Full Text] [Related]
19. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. Campbell MJ, Wollish WS, Lobo M, Esserman LJ. In Vitro Cell Dev Biol Anim; 2002 Jun 15; 38(6):326-33. PubMed ID: 12513120 [Abstract] [Full Text] [Related]
20. Promotion of breast cancer by beta-hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice. Wong PS, Matsumura F. BMC Cancer; 2007 Jul 17; 7():130. PubMed ID: 17640349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]